Diabetes Research and Clinical Practice
Efficacy and safety of different once-weekly glucagon-like peptide-1 receptor agonists-A systematic review and Bayesian network meta-analysis
Meta-analysisInterventions
Declared no competing interests
- GLP-1 receptor agonists
- Dulaglutide
- GLP-1 and incretin signalling
- Cardiovascular disease
- Type 2 diabetes
- Humans
The paper
Shanghai Jiao Tong University
Diabetes Research and Clinical Practice, 24 Oct 2025
